Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist
Phase II Study Evaluating the Safety and Efficacy of NerVFIX Treatment for Trauma or Accidental Nerve Section of the Wrist
Sponsor: TBF Genie Tissulaire
Terminated
Low accrual rate
Listed as NCT05199155, this PHASE2 trial focuses on Nerve Injury and Nerve Lesion and remains terminated or withdrawn. Sponsored by TBF Genie Tissulaire, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Dec 2024 — Present [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Jun 2023 — Jul 2024 [monthly]
Recruiting PHASE2
-
Mar 2022 — Jun 2023 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE2
First recorded
Dec 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- TBF Genie Tissulaire
For direct contact, visit the study record on ClinicalTrials.gov .